Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF)

13 filings reported holding PROCF - Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share as of Q1 2024.
Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 89,855 shares of 2,461,355,158 outstanding shares and own 0% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (28,938 shares), RENAISSANCE TECHNOLOGIES LLC (25,300 shares), CITADEL ADVISORS LLC (12,500 shares), STATE STREET CORP (12,363 shares), Activest Wealth Management (10,000 shares), Royal Bank of Canada (362 shares), Pineridge Advisors LLC (250 shares), MORGAN STANLEY (100 shares), UBS Group AG (42 shares), and Exome Asset Management LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.